NCT03863210

Brief Summary

Patient education in lifestyle changes has a positive effect on health in individuals with cardiovascular (CV) risk Despite current positive evidence about lifestyle and dietary change in the prevention of CVD, the recommendations are still not consistently and optimally applied to women, particularly in relation to their menopausal status. More information is needed about factors that will support effective implementation of educational interventions for decreasing CV risk. The aim of our study was to analyze the effect of an educational intervention, presented as a 60-minute lecture in primary health care setting about CV risk factors to women with different menopausal status, in relation to their decisional conflict about their treatment for CV risk and hope that their health will improve according to desired expectations.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

February 28, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 5, 2019

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

October 9, 2020

Completed
Last Updated

October 9, 2020

Status Verified

February 1, 2019

Enrollment Period

6 months

First QC Date

February 28, 2019

Results QC Date

August 24, 2020

Last Update Submit

September 16, 2020

Conditions

Keywords

cardiovascular riskpatient educationhopedecisional conflictwomen

Outcome Measures

Primary Outcomes (3)

  • Ten Year Risk of Cardiovascular Disease (CVD)

    Ten-year risk of fatal CVD was estimated using the ACC/AHA (American College of Cardiology/American Heart Association) guidelines, based on the following data collected from the study participants: age, gender, race, total and HDL (high-density lipoprotein) cholesterol, systolic blood pressure, data about antihypertensive therapy, diabetes mellitus and smoking status.

    Change from baseline 10-year risk of CVD at 3 months

  • Decisional Conflict (DC)

    DC was estimated using Decisional Conflict Scale (DCS) consist of 16 items rated in a 5-point Likert-type response format, and measures individual's uncertainty toward a course of action. There are five subscales: uncertainty, informed, values clarity, support and effective decision. The scores on the total scale and subscales are calculated as a sum of items, divided by the number of items and multiplied by 25, allowing for a score range from zero (no decisional conflict) to 100 points (extreme decisional conflict). The Croatian version of the scale was previously validated.

    Change from baseline DC at 3 months

  • State Hope

    State hope was estimated using Integrative Hope Scale (IHS), 23-items scale, a self-rating instrument with items being rated on a six-point Likert scale from 1, strongly disagree, to 6, strongly agree. It provides an overall score and four dimension scores, obtained by summing up the individual item scores, with negative items being rated inversely. This produces possible overall hope scores ranging from 23 to 138 with higher scores representing higher hopefulness. The scores for the sub-dimensions vary according to the number of items. The Croatian version of the scale was previously validated.

    Change from baseline state hope at 3 months

Secondary Outcomes (3)

  • Waist Circumference

    Change from baseline waist circumference at 3 months

  • Hips Circumference

    Change from baseline hips circumference at 3 months

  • Weight

    Change from baseline weight at 3 months

Study Arms (1)

Participants who received informations about lifestyle change

EXPERIMENTAL
Other: 60-minute lecture titled "Change of lifestyle and nutrition habits to reduce cardiovascular risk"

Interventions

All participants were exposed to the intervention. The intervention consisted of a 60-minute lecture titled "Change of lifestyle and nutrition habits to reduce cardiovascular risk". The lecture was delivered in family medicine offices by four specialists of family medicine individually to the groups of 6-8 participants. The lecture was verbal, harmonized among four family physicians, and contained instructions for changing nutrition habits, smoking habits and instructions for increasing physical activity. At the end of the lecture, each participant received a personally tailored decision aid, which included the list of her risk factors, assessment of the 10-year risk of fatal CVD (based on the data provided by the participants before the lecture), and instructions on what she should do in terms of changing the lifestyle habits.

Participants who received informations about lifestyle change

Eligibility Criteria

Age45 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • female sex
  • age 45 to 60 years
  • one or more CV risk factors \[overweight or obesity, i. e. body mass index (BMI) ≥25 kg/m2, and/or central obesity - waist circumference ≥88 cm, high blood pressure (systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg), high blood cholesterol (≥5.2 mmol/L) and active smoking\]
  • participants on antihypertensive therapy were also included in the study

You may not qualify if:

  • current cardiovascular disease (CVD) (ischemic heart disease, peripheral artery disease, and stroke)
  • malignant diseases
  • serious systemic or mental diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Limitations and Caveats

These results should be considered in view of the limitation that we could not use a control group in the setting where the intervention was delivered.

Results Point of Contact

Title
Dr. Slavica Jurić Petričević
Organization
University of Split School of Medicine

Study Officials

  • Slavica Jurić Petričević

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2019

First Posted

March 5, 2019

Study Start

March 1, 2014

Primary Completion

September 1, 2014

Study Completion

March 1, 2015

Last Updated

October 9, 2020

Results First Posted

October 9, 2020

Record last verified: 2019-02